These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29553848)

  • 1. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.
    Tourjman SV; Juster RP; Purdon S; Stip E; Kouassi E; Potvin S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):49-56. PubMed ID: 29553848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry.
    Tourjman SV; Potvin S; Corbalan F; Djouini A; Purdon SE; Stip E; Juster RP; Kouassi E
    Atten Defic Hyperact Disord; 2019 Jun; 11(2):139-147. PubMed ID: 30225804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
    Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
    Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools.
    Ott CV; Bjertrup AJ; Jensen JH; Ullum H; Sjælland R; Purdon SE; Vieta E; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Jan; 190():607-615. PubMed ID: 26583350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools.
    Jensen JH; Støttrup MM; Nayberg E; Knorr U; Ullum H; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2015 Nov; 187():10-9. PubMed ID: 26301477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools.
    Jensen JH; Miskowiak KW; Purdon SE; Thomsen JF; Eller NH
    Scand J Work Environ Health; 2022 Jan; 48(1):71-80. PubMed ID: 34580738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile.
    Peavy GM; Salmon DP; Rice VA; Galasko D; Samuel W; Taylor KI; Ernesto C; Butters N; Thal L
    Arch Neurol; 1996 Apr; 53(4):367-72. PubMed ID: 8929160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
    Rojo E; Pino O; Guilera G; Gómez-Benito J; Purdon SE; Crespo-Facorro B; Cuesta MJ; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Mesa F; Rejas J;
    Schizophr Res; 2010 Feb; 116(2-3):243-51. PubMed ID: 19744832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls.
    Bo Q; Dong F; Li X; Li F; Li P; Yu H; He F; Zhang G; Wang Z; Ma X; Wang C
    Psychiatry Clin Neurosci; 2019 Feb; 73(2):70-76. PubMed ID: 30393945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Deficits in the THINC-Integrated Tool (THINC-it) Are Associated With Psychosocial Dysfunction in Patients With Major Depressive Disorder.
    Knight MJ; Fourrier C; Lyrtzis E; Aboustate N; Sampson E; Hori H; Mills NT; Baune BT
    J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of subjective vs. objective remission status on subjective cognitive impairments in depression.
    Sawada K; Yoshida K; Ozawa C; Mizuno Y; Rubinstein EB; Suzuki T; Mimura M; Uchida H
    J Affect Disord; 2019 Mar; 246():99-104. PubMed ID: 30578953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The screen for cognitive impairment in psychiatry (SCIP) as a routinely applied screening tool: pathology of acute psychiatric inpatients and cluster analysis.
    Schmid P; Czekaj A; Frick J; Steinert T; Purdon SE; Uhlmann C
    BMC Psychiatry; 2021 Oct; 21(1):494. PubMed ID: 34627191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
    Belvederi Murri M; Folesani F; Costa S; Biancosino B; Colla C; Zerbinati L; Caruso R; Nanni MG; Purdon SE; Grassi L
    Schizophr Res; 2020 Apr; 218():188-194. PubMed ID: 31948897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Cognitive Impairment on the Prognosis of Major Depressive Disorder.
    Zhang BH; Feng L; Feng Y; Xin LM; Zhu XY; Tan YL; Wang G
    J Nerv Ment Dis; 2020 Sep; 208(9):683-688. PubMed ID: 32433202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is normal cognition in depression? Prevalence and functional correlates of normative versus idiographic cognitive impairment.
    Tran T; Milanovic M; Holshausen K; Bowie CR
    Neuropsychology; 2021 Jan; 35(1):33-41. PubMed ID: 33393798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in Malaysian patients with major depressive disorder: A subgroup analysis of a multicountry, cross-sectional study.
    Zainal NZ; Kalita P; Herr KJ
    Asia Pac Psychiatry; 2019 Mar; 11(1):e12346. PubMed ID: 30511420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between clinical characteristics and cognitive deficits among adult patients diagnosed with major depressive disorder.
    Subhas N; Ang JK; Tan KA; Ahmad SNA
    Int J Psychiatry Clin Pract; 2023 Sep; 27(3):219-231. PubMed ID: 36448673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.